» Articles » PMID: 36120455

Connexin 43 (Cx43) Regulates High-glucose-induced Retinal Endothelial Cell Angiogenesis and Retinal Neovascularization

Overview
Specialty Endocrinology
Date 2022 Sep 19
PMID 36120455
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic retinopathy (DR) is an important microvascular complication of type 1 and type 2 diabetes mellitus (DM) and a major cause of blindness. Retinal neovascularization plays a critical role in the proliferative DR. In this study, high glucose-induced connexin 43 (Cx43) expression in human retinal endothelial cells (hRECs) in a dose-dependent manner. Compared with hRECs under normal culture conditions, high-glucose (HG)-stimulated hRECs showed promoted tubule formation, increased ROS release, and elevated levels of tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), vascular endothelial growth factor A (VEGFA), and intercellular adhesion molecule 1 (ICAM-1) in the culture medium. HG-induced alterations were further magnified after overexpression, whereas partially eliminated after knockdown. Finally, in the DR mouse model, impaired retinal structure, increased CD31 expression, and elevated mRNA levels of , , , and were observed; knockdown partially reversed these phenomena. Conclusively, knockdown could inhibit hREC angiogenesis, therefore improving DR in the mouse model.

Citing Articles

Revamping anti-cGAS-STING therapy via an injectable thermo-responsive supramolecular hydrogel for pathological retinal angiogenesis.

Yan D, Wang Y, Ouyang W, Huang C, Chen Q, Hu J Asian J Pharm Sci. 2024; 19(5):100969.

PMID: 39474128 PMC: 11513468. DOI: 10.1016/j.ajps.2024.100969.


Inhibition of ADAM17 attenuates high glucose-induced angiogenesis and inflammation in endothelial cells partly through down-regulation of GRO-α/CXCR2 expression: implications in peritoneal dialysis.

Jiang N, Feng H, Xie W, Gu L, Fang W, Ding T Clin Exp Nephrol. 2024; 28(12):1232-1240.

PMID: 39305454 PMC: 11621206. DOI: 10.1007/s10157-024-02546-y.


Protector Role of Cx30.2 in Pancreatic β-Cell against Glucotoxicity-Induced Apoptosis.

Ortega-Cuellar D, Gonzalez-Sanchez I, Pinon-Zarate G, Cerbon M, De la Rosa V, Franco-Juarez Y Biology (Basel). 2024; 13(7).

PMID: 39056663 PMC: 11273625. DOI: 10.3390/biology13070468.


Therapeutic Delivery of Soluble Fractalkine Ameliorates Vascular Dysfunction in the Diabetic Retina.

Rodriguez D, Church K, Smith C, Vanegas D, Cardona S, Muzzio I Int J Mol Sci. 2024; 25(3).

PMID: 38339005 PMC: 10855319. DOI: 10.3390/ijms25031727.


Opening of Cx43-formed hemichannels mediates the Ca signaling associated with endothelial cell migration.

Espinoza H, Figueroa X Biol Direct. 2023; 18(1):52.

PMID: 37635249 PMC: 10463847. DOI: 10.1186/s13062-023-00408-3.


References
1.
Thomas A, Biswas S, Feng B, Chen S, Gonder J, Chakrabarti S . lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy. Diabetologia. 2019; 62(3):517-530. DOI: 10.1007/s00125-018-4797-6. View

2.
Stitt A, Curtis T, Chen M, Medina R, Mckay G, Jenkins A . The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2015; 51:156-86. DOI: 10.1016/j.preteyeres.2015.08.001. View

3.
Ford J, Elders A, Shyangdan D, Royle P, Waugh N . The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review. BMJ. 2012; 345:e5182. PMC: 3418219. DOI: 10.1136/bmj.e5182. View

4.
Flyvbjerg A . Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily. Nat Rev Endocrinol. 2010; 6(2):94-101. DOI: 10.1038/nrendo.2009.266. View

5.
Lee R, Wong T, Sabanayagam C . Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015; 2:17. PMC: 4657234. DOI: 10.1186/s40662-015-0026-2. View